Bill
SB 2756
SB 2756 would create an Alternative Funding Task Force from Mississippi Rare Disease Advisory Council members to explore and propose alternative funding options for public health i
SB 2756 — Alternative Funding Task Force; create from members of the Mississippi Rare Disease Advisory Council
Overview
- Bill Number: SB 2756
- Title: Alternative Funding Task Force; create from members of the Mississippi Rare Disease Advisory Council
- Subject: Public Health and Welfare
- Purpose (as stated): Create an Alternative Funding Task Force drawn from members of the Mississippi Rare Disease Advisory Council to assess and propose alternative funding options for relevant public health initiatives.
- Status: Died In Committee (did not advance in the session)
Key Provisions (as Available)
- Establishment of an Alternative Funding Task Force.
- Membership: the Task Force would be created from members of the Mississippi Rare Disease Advisory Council.
- Specific duties, powers, appointment processes, term lengths, funding, meeting requirements, and reporting obligations are not detailed in the provided information.
Affected Parties
- Mississippi Rare Disease Advisory Council members (potential Task Force appointees by virtue of Council membership).
- State public health and welfare agencies that would interact with or respond to the Task Force’s work, pending further statutory details.
- Stakeholders in Mississippi health policy and rare disease initiatives who could be impacted by funding-related recommendations.
Procedural History and Timeline
- January 20, 2025: Referred to Public Health and Welfare.
- February 4, 2025: Died In Committee (first committee action recorded).
- March 14, 2025: Introduced; Filed; Received by the Secretary of the Senate.
- April 3, 2025: Read first time; Referred to Criminal Justice (procedural steps underway in the Senate at that time).
- Current status: Died In Committee (no indication of movement beyond committee in the provided record).
Potential Impact and Context
- If enacted, SB 2756 would create a formal body to explore and recommend alternative funding sources for public health programs, particularly those related to rare disease initiatives.
- The Task Force could influence future funding strategies, including grants, partnerships, or novel funding mechanisms, and may inform legislative considerations on sustainability of health programs.
- Because the bill did not progress past committee, its proposals did not become law in the current session. Any future consideration would require new sponsorship, committee action, and reflective alignment with budget and health policy priorities.
Notes
- The provided information does not include specific provisions on composition size, appointment methodology, term limits, meeting schedules, reporting requirements, or funding for the Task Force.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
